Xiaofeng Zheng

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.896Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis

Microbiology Spectrum(2022)10.1128/spectrum.01692-21

Top 23%

0.896DataRank

Top 23%28 citations

Diego Santos-García, Xiaofeng Zheng, Li Zhang, Xiang Y. Han, Francisco J. Silva

Papers

Driven by 22 papers — median percentile 77. Top paper: “Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis”.

Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis

Microbiology Spectrum(2022)10.1128/spectrum.01692-21

Top 23%

0.896DataRank

Top 23%28 citations

Diego Santos-García, Xiaofeng Zheng, Li Zhang, Xiang Y. Han, Francisco J. Silva

BM-SNP: A Bayesian Model for SNP Calling Using High Throughput Sequencing Data

IEEE/ACM Transactions on Computational Biology and Bioinformatics(2014)10.1109/tcbb.2014.2321407

N/A

0.208DataRank · unranked

3 citations

Xiaofeng Zheng, Yuan Yuan, Marcos R Estecio, Jean-Pierre Issa, Peng Qiu +3 more

Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer

Cell Reports(2021)10.1016/j.celrep.2021.108990

N/A

0DataRank · unranked

89 citations

Sujuan Yang, Pedro Corrêa de Sampaio, Xiaofeng Zheng, Souptik Barua, Kathleen M. McAndrews +5 more

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models

Breast Cancer Research(2021)10.1186/s13058-021-01406-x

N/A

0DataRank · unranked

70 citations

Ming Zhao, Erkan Yuca, Allen Annis, Kurt W. Evans, David Sutton +13 more

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4048

N/A

0DataRank · unranked

28 citations

Xiaofeng Zheng, Christian X. Cruz Pico, Tae‐Beom Kim, Ken Chen, Anil Korkut +9 more

Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-20-1484

N/A

0DataRank · unranked

304 citations

Yang Chen, J. Kebbeh Darpolor, Xiaofeng Zheng, Sujuan Yang, Julienne L. Carstens +11 more

Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations

Scientific Reports(2022)10.1038/s41598-022-05193-z

N/A

0DataRank · unranked

9 citations

Argun Akçakanat, Scott Kopetz, Coya Tapia, Xiaofeng Zheng, Huiqin Chen +12 more

HepaCAM Suppresses Glioblastoma Stem Cell Invasion in the Brain

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.24.504654

N/A

0DataRank · unranked

3 citations

John Lattier, John E. Morales, Jack R. Kelly, Xiaofeng Zheng, Zhihua Chen +5 more

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

Research Square(2022)10.21203/rs.3.rs-2248209/v1

N/A

0DataRank · unranked

0 citations

Turçin Saridogan, Argun Akçakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca +11 more

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0103

N/A

0DataRank · unranked

29 citations

Kurt W. Evans, Maria Gabriela Raso, Ming Zhao, Yasmeen Q. Rizvi, Xiaofeng Zheng +11 more

Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities

Journal of Thoracic Disease(2020)10.21037/jtd.2020.01.42

N/A

0DataRank · unranked

8 citations

K. G. Mitchell, Jing Wang, Junya Fujimoto, Myrna C. B. Godoy, Carmen Behrens +16 more

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

Scientific Reports(2023)10.1038/s41598-023-46586-y

N/A

0DataRank · unranked

15 citations

Argun Akçakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca, Stephen Scott +11 more

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer

Cancer(2023)10.1002/cncr.34773

N/A

0DataRank · unranked

5 citations

Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina A. Piha‐Paul, Julia Ann Moore +18 more

Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0838

N/A

0DataRank · unranked

25 citations

Kurt W. Evans, Bailiang Wang, Ming Zhao, Argun Akçakanat, Maria Gabriela Raso +14 more

Antitumor Activity and Biomarker Analysis for TROP2 Antibody–Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1948

N/A

0DataRank · unranked

22 citations

Erkan Yuca, Kurt W. Evans, Ming Zhao, Takanori Maejima, Tsuyoshi Karibe +12 more

Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1233

N/A

0DataRank · unranked

1 citations

Kurt W. Evans, Stephen Scott, Xiaofeng Zheng, Kaushik Varadarajan, Lawrence N. Kwong +16 more

STAT3 mediates an inflammation-induced microbial defense response and regulates pathogen control and clearance by macrophages

The Journal of Immunology(2025)10.1093/jimmun/vkaf309

N/A

0DataRank · unranked

3 citations

Xiaofeng Zheng, Laura M. Kahn, Sarah M. Schneider, Josué E. Pineda, Morgan Riba +6 more

Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131)

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3531

N/A

0DataRank · unranked

3 citations

Filip Jankú, Ying Yuan, Leylah Drusbosky, Alice P. Chen, Xiaofeng Zheng +15 more

Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0884

N/A

0DataRank · unranked

1 citations

Christian X. Cruz Pico, Kurt W. Evans, Maria Gabriela Raso, Yasmeen Q. Rizvi, Xiaofeng Zheng +10 more

Rbm25 governs embryonic stem cell identity and fate through transcriptional regulation of pluripotency and epigenetic programs

Stem Cell Reports(2025)10.1016/j.stemcr.2025.102748

N/A

0DataRank · unranked

0 citations

Linlin Zhang, Peng Cao, Shengjun Bai, Meilin Sun, Jialun Li +10 more

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan

npj Breast Cancer(2023)10.1038/s41523-023-00573-8

N/A

0DataRank · unranked

29 citations

Timothy P. DiPeri, Maria Gabriela Raso, Xiaofeng Zheng, Yasmeen Qamar Rizvi, Kurt W. Evans +8 more

NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity

Nature Immunology(2021)10.1038/s41590-020-00829-6

N/A

0DataRank · unranked

121 citations

Xiaofei Zhou, Jee Hyung Sohn, Lele Zhu, Zuliang Jie, Jin‐Young Yang +10 more

Xiaofeng Zheng

Indexed papers

Top data-sharing exemplar

Papers